Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis.

Ahmet L SertdemirAhmet Taha SahinMustafa DuranMustafa ÇelikSefa Tatarİrem OktayYakup Alsancak

Published in: Medicine (2024)

Our data indicate that serum SDC4 levels provide comprehensive information about the clinical activity of the disease and subclinical atherosclerosis in AS patients.

Keyphrases

ankylosing spondylitis
end stage renal disease
cardiovascular disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
disease activity
electronic health record
healthcare
patient reported outcomes
health information